These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 9156411

  • 21. Low molecular weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.
    Hirsh J, Crowther M.
    Thromb Haemost; 1997 Jul; 78(1):689-92. PubMed ID: 9198240
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD, Pineo GF, Stein P.
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Low molecular heparin in prevention of thrombosis in orthopedic surgery].
    Jensen HP, Borris LC, Lassen MR, Sørensen JV, Rahr HB, Christiansen HM, Ejstrud P.
    Ugeskr Laeger; 1993 Apr 12; 155(15):1109-15. PubMed ID: 8387708
    [Abstract] [Full Text] [Related]

  • 29. Low molecular weight heparin (Alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures.
    Pini M, Tagliaferri A, Manotti C, Lasagni F, Rinaldi E, Dettori AG.
    Int Angiol; 1989 Apr 12; 8(3):134-9. PubMed ID: 2556484
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Low molecular weight heparins].
    Agnelli G, Cosmi B.
    Medicina (Firenze); 1990 Apr 12; 10(1):9-15. PubMed ID: 2166209
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Treatment of deep venous thrombosis with low-molecular-weight heparin during pregnancy.
    Ulander VM, Stenqvist P, Kaaja R.
    Thromb Res; 2002 Apr 01; 106(1):13-7. PubMed ID: 12165283
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. One-month versus six-month therapy with oral anticoagulants after symptomatic deep vein thrombosis.
    Holmgren K, Andersson G, Fagrell B, Johnsson H, Ljungberg B, Nilsson E, Wilhelmsson S, Zetterquist S.
    Acta Med Scand; 1985 Apr 01; 218(3):279-84. PubMed ID: 3907286
    [Abstract] [Full Text] [Related]

  • 38. [Evaluation of an intervention on the prescription and biological surveillance of low-molecular weight heparins in medicine].
    Fiessinger JN, Chatellier G.
    Presse Med; 1996 Nov 23; 25(36):1777-80. PubMed ID: 8991025
    [Abstract] [Full Text] [Related]

  • 39. Treatment dosing of low-molecular-weight heparins and the dose cap dilemma: considerations for patients in Canada.
    Thomson P, Brocklebank C, Semchuk W.
    Can J Hosp Pharm; 2009 Sep 23; 62(5):367-74. PubMed ID: 22478918
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.